These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 23220026)

  • 1. A theoretical model for the production of Ac-225 for cancer therapy by neutron capture transmutation of Ra-226.
    Melville G; Melville P
    Appl Radiat Isot; 2013 Feb; 72():152-7. PubMed ID: 23220026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A theoretical model for the production of Ac-225 for cancer therapy by photon-induced transmutation of Ra-226.
    Melville G; Fan Liu S; Allen BJ
    Appl Radiat Isot; 2006 Sep; 64(9):979-88. PubMed ID: 16806950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclotron and linac production of Ac-225.
    Melville G; Allen BJ
    Appl Radiat Isot; 2009 Apr; 67(4):549-55. PubMed ID: 19135381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of Ac-225 for cancer therapy by photon-induced transmutation of Ra-226.
    Melville G; Meriarty H; Metcalfe P; Knittel T; Allen BJ
    Appl Radiat Isot; 2007 Sep; 65(9):1014-22. PubMed ID: 17532223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actinium-225 photonuclear production in nuclear reactors using a mixed radium-226 and gadolinium-157 target.
    Matyskin AV; Angermeier SB; Drera SS; Prible MC; Geuther JA; Heibel MD
    Nucl Med Biol; 2024; 136-137():108940. PubMed ID: 39002498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Light charged-particle production in 96 MeV neutron-induced reactions on carbon and oxygen.
    Tippawan U; Pomp S; Blomgren J; Dangtip S; Johansson C; Klug J; Mermod P; Nilsson L; Ohrn A; Osterlund M; Olsson N; Prokofiev AV; Nadel-Turonski P; Corcalciuc V; Koning AJ; Watanabe Y
    Radiat Prot Dosimetry; 2007; 126(1-4):35-9. PubMed ID: 17496294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactor production of Thorium-229.
    Hogle S; Boll RA; Murphy K; Denton D; Owens A; Haverlock TJ; Garland M; Mirzadeh S
    Appl Radiat Isot; 2016 Aug; 114():19-27. PubMed ID: 27163437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential production of Ac-225 at Egyptian second research reactor (ETRR-2) through neutron induced transmutation of Ra-226.
    Gizawy MA; Mohamed NMA
    Appl Radiat Isot; 2024 Mar; 205():111176. PubMed ID: 38217940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of actinium-225 for alpha particle mediated radioimmunotherapy.
    Boll RA; Malkemus D; Mirzadeh S
    Appl Radiat Isot; 2005 May; 62(5):667-79. PubMed ID: 15763472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of an accelerator-based neutron source for neutron capture therapy.
    Terlizzi R; Colonna N; Colangelo P; Maiorana A; Marrone S; Rainò A; Tagliente G; Variale V
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S292-5. PubMed ID: 19406649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation binary targeted therapy for HER-2 positive breast cancers: assumptions, theoretical assessment and future directions.
    Mundy DW; Harb W; Jevremovic T
    Phys Med Biol; 2006 Mar; 51(6):1377-91. PubMed ID: 16510950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between the biological effects of high- and low-LET radiation dose components in a mixed field exposure.
    Mason AJ; Giusti V; Green S; Munck af Rosenschöld P; Beynon TD; Hopewell JW
    Int J Radiat Biol; 2011 Dec; 87(12):1162-72. PubMed ID: 21923301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intercalibration of physical neutron dosimetry for the RA-3 and MURR thermal neutron sources for BNCT small-animal research.
    Pozzi EC; Thorp S; Brockman J; Miller M; Nigg DW; Hawthorne MF
    Appl Radiat Isot; 2011 Dec; 69(12):1921-3. PubMed ID: 21330143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclotron production of Ac-225 for targeted alpha therapy.
    Apostolidis C; Molinet R; McGinley J; Abbas K; Möllenbeck J; Morgenstern A
    Appl Radiat Isot; 2005 Mar; 62(3):383-7. PubMed ID: 15607913
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Sánchez-Jiménez J; López-Montes A; Núñez-Martínez L; Villa-Abaunza A; Fraile LM; Sánchez-Tembleque V; Udías JM
    Phys Med; 2017 Mar; 35():97-101. PubMed ID: 28216330
    [No Abstract]   [Full Text] [Related]  

  • 16. [Neutron flow measurements in the d(14) + Be neutron radiation field from the cyclotron in Essen].
    Pöller F; Sauerwein W; Rau D; Wagner FM; Olthoff K; Rassow J; Sack H
    Strahlenther Onkol; 1990 Jun; 166(6):426-9. PubMed ID: 2363106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetry of 252Cf sources for neutron radiotherapy with and without augmentation by boron neutron capture therapy.
    Yanch JC; Zamenhof RG
    Radiat Res; 1992 Sep; 131(3):249-56. PubMed ID: 1438684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Boron neutron capture a a new radiotherapy model].
    Hideghéty K; Sauerwwein W; Rassuw J; Sack H
    Orv Hetil; 1998 Mar; 139(12):675-9. PubMed ID: 9555163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetry and radiobiology at the new RA-3 reactor boron neutron capture therapy (BNCT) facility: application to the treatment of experimental oral cancer.
    Pozzi E; Nigg DW; Miller M; Thorp SI; Heber EM; Zarza L; Estryk G; Monti Hughes A; Molinari AJ; Garabalino M; Itoiz ME; Aromando RF; Quintana J; Trivillin VA; Schwint AE
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S309-12. PubMed ID: 19380233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutron activation of patients following boron neutron capture therapy of brain tumors at the high flux reactor (HFR) Petten (EORTC Trials 11961 and 11011).
    Wittig A; Moss RL; Stecher-Rasmussen F; Appelman K; Rassow J; Roca A; Sauerwein W
    Strahlenther Onkol; 2005 Dec; 181(12):774-82. PubMed ID: 16362787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.